[Skip to Content]
[Skip to Content Landing]
Editorial
April 25, 2017

Screening for Preeclampsia and the USPSTF Recommendations

Author Affiliations
  • 1Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California-San Francisco
JAMA. 2017;317(16):1629-1630. doi:10.1001/jama.2017.2018

Preeclampsia is a condition characterized by the new onset of hypertension after 20 weeks of gestation, with proteinuria, evidence of organ dysfunction, or both in a previously normotensive woman.1 Preeclampsia and eclampsia complicate up to 10% of pregnancies and remain a leading cause of maternal and neonatal morbidity and mortality in the United States.2 The complications of preeclampsia in part shaped the development of prenatal care in the United States. The timing and frequency of visits were chosen to improve detection of preeclampsia through the measurement of blood pressure at routine prenatal visits.3

×